Awan, F. T., Schuh, A., Brown, J. R., Furman, R. R., Pagel, J. M., Hillmen, P., . . . Byrd, J. C. (2019). Acalabrutinib monotherapy in patients with chronic lymphocytic leukemia who are intolerant to ibrutinib. Blood Adv.
استشهاد بنمط شيكاغوAwan, Farrukh T., et al. "Acalabrutinib Monotherapy in Patients With Chronic Lymphocytic Leukemia Who Are Intolerant to Ibrutinib." Blood Adv 2019.
MLA استشهادAwan, Farrukh T., et al. "Acalabrutinib Monotherapy in Patients With Chronic Lymphocytic Leukemia Who Are Intolerant to Ibrutinib." Blood Adv 2019.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.